Deterministic or predictive profiles? How to optimize your HCP promotional activities across channels
We’re excited to share part three of our blog series about one of the most promising methodologies...
What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General...
Available Omnichannel HCP Data Sources
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share...
Biomarker Testing in Non-Small Cell Lung Cancer
By Bill Bowman, Clinical Solutions Architect
Clinical Diagnostic Data for Omnichannel HCP Marketing
A 5 Part Series By Matt Apprendi, VP of Digital Products We’re excited to write about one of the...
Innovative Models for Converting AI Data
Wouldn’t it be convenient if a doctor could simply upload a patient’s medical chart into an...
HbA1c scores influence HCPs’ therapy choices
Diabetes is one of many conditions where lab testing plays a critical role.